Reliability of a Newly-Developed Immunochromatography Diagnostic Kit for Pandemic Influenza A/H1N1pdm Virus: Implications for Drug Administration

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Sasaki, Tadahiro ^a   Kubota Koketsu, Ritsuko ^a   Takei, Michihiro ^b   Hagihara, Tatsuo ^b   Iwamoto, Shinichi ^b   Murao, Takuya ^b   Sawami, Kazuo ^b   Fukae, Daizou ^b   Nakamura, Masahiro ^b   Nagata, Eiichi ^b   Kawakami, Akira ^b   Mitsubayashi, Yuko ^b   Ohno, Masafumi ^b   Uehara, Yasuo ^b   Fukukawa, Takashi ^b   Kanai, Yuta ^a   Kosaka, Mieko ^c   Ikuta, Kazuyoshi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b Osaka Higashinari ku Medical Association   (Japan)

^c Alfresa Pharma Corporation   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LANINAMIVIR; OSELTAMIVIR; PERAMIVIR; ZANAMIVIR;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ALLERGY; ARTHRALGIA; ARTHRITIS; ARTICLE; ASTHMA; CHILD; CONTROLLED STUDY; COUGHING; CROSS REACTION; DIABETES MELLITUS; DIAGNOSTIC KIT; DIARRHEA; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FEVER; FLU LIKE SYNDROME; HEADACHE; HUMAN; HYPERTENSION; IMMUNOAFFINITY CHROMATOGRAPHY; INFANT; INFLUENZA A; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS B; JAPAN; KIDNEY DISEASE; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALAISE; MALE; MYALGIA; NAUSEA; NOSE DISEASE; PANDEMIC INFLUENZA; POINT OF CARE TESTING; PREDICTIVE VALUE; PRESCHOOL CHILD; PRESCRIPTION; QUESTIONNAIRE; RELIABILITY; REVERSE TRANSCRIPTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SORE THROAT; SYMPTOMATOLOGY; VIRUS ISOLATION; VOMITING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; DOGS; DRUG PRESCRIPTIONS; FEMALE; HUMANS; IMMUNOCHROMATOGRAPHY; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MADIN DARBY CANINE KIDNEY CELLS; MALE; MIDDLE AGED; PANDEMICS; POINT-OF-CARE SYSTEMS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; TIME FACTORS; YOUNG ADULT;

CERCOPITHECINE HERPESVIRUS 1; INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 84870604667     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050670     Document Type: Article

References (35)

1. European Centre for Disease Prevention and Control (2010) ECDC Daily Update - Pandemic (H1N1) 2009-18 January 2010". European Centre for Disease Prevention and Control. 18 January 2010.
2. World Health Organization; Influenza Laboratory Surveillance Information by the Global Influenza Surveillance and Response System (GISRS). Available at http://www.who.int/influenza/gisrs_laboratory/en/.
3. Neumann G, Noda T, Kawaoka Y, (2009) Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459: 931-939.
4. Vaillant L, La Ruche G, Tarantola A, Barboza P, epidemic intelligence team at InVS (2009) Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Eurosurveillance 14.
5. Centers for Disease Control and Prevention (CDC) (2010) Update: influenza activity- United States, 2009-10 season. MMWR 59: 901-908.
6. WHO (2010) Update on oseltamivir-resistant pandemic A (H1N1) 2009 influenza, virus: January 2010. Weekly Epidemiological Record on pandemic (H1N1), 2009 85: 3.
7. Ramirez-Gonzalez JE, Gonzalez-Duran E, Alcantara-Perez P, Wong-Arambula C, Olivera-Diaz H, et al. (2011) Oseltamivir-resistant pandemic (H1N1) 2009 virus, Mexico. Emerg Infect Dis 17: 283-286.
8. Kiso M, Shinya K, Shimojima M, Takano R, Takahashi K, et al. (2010) Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses. PLoS Pathog 6: e1001079.
9. Rungrotmongkol T, Intharathep P, Malaisree M, Nunthaboot N, Kaiyawet N, et al. (2009) Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus. Biochem Biophys Res Commun 385: 390-394.
10. Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD, et al. (2009) Pandemic potential of a strain of influenza A (H1N1): early findings. Science 324: 1557-1561.
11. Garske T, Legrand J, Donnelly CA, Ward H, Cauchemez S, et al. (2009) Assessing the severity of the novel influenza A/H1N1 pandemic. BMJ 339: b2840.
12. Chowell G, Echevarria-Zuno S, Viboud C, Simonsen L, Tamerius J, et al. (2011) Characterizing the epidemiology of the 2009 influenza A/H1N1 pandemic in Mexico. PLoS Med 8: e1000436.
13. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, et al. (2009) In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460: 1021-1025.
14. Presanis AM, De Angelis D, Hagy A, Reed C, Riley S, et al. (2009) The severity of pandemic H1N1 influenza in the Unites States, from April to July 2009: a Bayesian analysis. PLoS Med 6: e1000207.
15. Tuite AR, Greer AL, Whelan M, Winter AL, Lee B, et al. (2010) Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza. CMAJ 182: 131-136.
16. Sugaya N, Shinjoh M, Mitamura K, Takahashi T, (2011) Very low pandemic influenza A (H1N1) 2009 mortality associated with early neuraminidase inhibitor treatment in Japan: analysis of 1000 hospitalized children. J Infect 63: 288-94.
17. Kamigaki T, Oshitani H (2009) Epidemiological characteristics and low case fatality rate of pandemic (H1N1) 2009 in Japan. PLoS Curr. 1, RPN1139.
18. Faix DJ, Sherma SS, Waterman SH, (2009) Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humans. N Eng J Med 361: 728-729.
19. Herzum I, Lutz T, Koch F, Geisel R, Gehrt A, (2010) Diagnostic performance of rapid influenza antigen assays in patients infected with the new influenza A (H1N1) virus. Clin Chem Lab Med 48: 53-56.
20. Kok J, Blyth CC, Foo H, Patterson J, Taylor J, et al. (2010) Comparison of a rapid antigen test with nucleic acid testing during cocirculation of pandemic influenza A/H1N1 2009 and seasonal influenza A/H3N2. J Clin Microbiol 48: 290-291.
21. Louie JK, Guevara H, Boston E, Dahlke M, Mevarez M, et al. (2010) Rapid influenza antigen test for diagnosis of pandemic (H1N1) 2009. Emerg Infect Dis 16, 824-826.
22. Drezler JF, Helmer A, Kirberg H, Reber U, Panning M, et al. (2009) Poor clinical sensitivity of rapid antigen test for influenza A pandemic (H1N1) 2009 virus. Emerg Infect Dis 15, 1662-1664.
23. Gordon A, Videa E, Saborio S, Lopez R, Kuan G, et al. (2010) Diagnostic accuracy of a rapid influenza test for pandemic influenza A H1N1. PLoS One 5, e10364.
24. Suntarattiwong P, Jarman RG, Levy J, Baggett HG, Gibbons RV, et al. (2010) Clinical performance of a rapid influenza test and comparison of nasal versus throat swabs to detect 2009 pandemic influenza A (H1N1) infection in Thai children. Pediatr Infect Dis J 29, 366-367.
25. Vasoo S, Stevens J, Singh K (2009) Rapid antigen tests for diagnosis of pandemic (Swine) influenza A/H1N1. Clin Infect Dis 49, 1090-1093.
26. Watcharananan S, Kiertiburanakul S, Chantratita W (2010) Rapid influenza diagnostic test during the outbreak of the novel influenza A/H1N1 2009 in Thailand: an experience with better test performance in resource limited setting. J Infect 60, 86-87.
27. Mizuike R, Sasaki T, Baba K, Iwamoto H, Shibai Y, et al. (2011) Development of two types of rapid diagnostic test kits to detect the hemagglutinin or nucleoprotein of the swine-origin pandemic influenza A virus H1N1. Clin Vaccine Immunol 18: 494-499.
28. Choi WS, Noh JY, Huh JY, Kee SY, Jeong HW, et al. (2011) The clinical usefulness of the SD Bioline Influenza Antigen Test® for detecting the 2009 influenza A (H1N1) virus. Yonsei Med J 52: 683-685.
29. Kawachi S, Matsushita T, Sato T, Nunoi H, Noguchi H, et al. (2011) Multicenter prospective evaluation of a novel rapid immunochromatographic diagnostic kit specifically detecting influenza A H1N1 2009 virus. J Clin Virol 51: 68-72.
30. Choi YJ, Kim HJ, Park JS, Oh MH, Nam HS, et al. (2010) Evaluation of new rapid antigen test for detection of pandemic influenza A/H1N1 2009 virus. J Clin Microbiol 48: 2260-2262.
31. Miyoshi-Akiyama T, Narahara K, Mori S, Kitajima H, Kase T, et al. (2010) Development of an immunochromatographic assay specifically detecting pandemic H1N1 (2009) influenza virus. J Clin Microbiol 48: 703-708.
32. Gentile D, Doyle W, Whiteside T, Fireman P, Hayden FG, et al. (1998) Increased interleukin-6 levels in nasal lavage samples following experimental influenza A virus infection. Clin Diagn Lab Immunol 5: 604-608.
33. Kiso M, Mitamura K, Sakai-Tagawa Y, Shiraishi K, Kawakami C, et al. (2004) Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 364: 759-765.
34. Zhu H, Zhou B, Fan X, Lam TT, Wang J, et al. (2011) Novel reassortment of eurasian avian-like and pandemic/2009 influenza viruses in Swine: infectious potential for humans. J Virol 85: 10432-10439.
35. Centers for Disease Control and Prevention (CDC) (2011) Swine-Origin Influenza A (H3N2) Virus Infection in Two Children - Indiana and Pennsylvania, July-August 2011. MMWR Morb Mortal Wkly Rep 60: 1213-1215.